You may notice your appetite and portion sizes changing within the first few weeks
[3] The mechanisms underlying triglyceride reduction with Mounjaro are multifactorial and likely include: Weight loss : Reduction in adipose tissue decreases hepatic very-low-density lipoprotein (VLDL) production, the primary carrier of triglycerides in the blood [12] Improved insulin sensitivity : Enhanced insulin action reduces hepatic lipogenesis (fat synthesis) and increases lipoprotein lipase activity, promoting triglyceride clearance Reduced caloric intake : Appetite suppression leads to decreased dietary fat consumption Direct metabolic effects : GIP and GLP-1 receptor activation may influence lipid metabolism through pathways that are not yet fully understood It is important to emphasise that there is no official indication for Mounjaro as a lipid-lowering agent, and treatment decisions should be based on its licensed use for type 2 diabetes
Plain ascorbic acid is fantastic but notoriously fragile
Regular monitoring by your provider ensures your progress aligns with expected outcomes, refining dosages as needed to support consistent weight loss
36 Because appetite reduction is common with GLP-1 agonists, and many individuals on GLP-1 therapies are counseled to prioritize protein and/or follow a ketogenic diet to support muscle maintenance during weight loss, fiber intake is often reduced significantly as fruits, vegetables and grains are eliminated
Compounded oral drops have no reliable head-to-head data proving equivalent weight-loss outcomes to the branded injectables